TCT-245 Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

Article2013

TCT-36 One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSORB EXTEND Trials.

Takashi Muramatsu, Yoshinobu Onuma, Robert J. Van Geuns, Bernard Chevalier, Tejas Patel, Ashok Seth, Roberto Diletti, Héctor M. García‐García, Cécile Dorange, Susan Veldhof, Wai‐Fung Cheong, Robert Whitbourn, Antonio L. Bartorelli, Alexandre Abizaid, Patrick W. Serruys

Journal of the American College of Cardiology

Article2016

TCT-60 1-year Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis from the ABSORB Randomized Trials

Ariel Furer, Ori Ben‐Yehuda, Björn Redfors, Patrick W. Serruys, Runlin Gao, Takeshi Kimura, Dean J. Kereiakes, Stephen G. Ellis, Weiying Zhao, Minh-Thien Vu, Yoshinobu Onuma, Gregg W. Stone

Journal of the American College of Cardiology

Article2018

TCT-62 Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

Patrick W. Serruys, Bernard Chevalier

Journal of the American College of Cardiology

Article2014

TCT-624 Impact of Post Dilation on the Acute and One-Year Clinical Outcomes of a Large Cohort of Patients Treated Solely With the Absorb Bioresorbable Vascular Scaffold

J. Ribamar Costa, Alexandre Abizaid, Antonio L. Bartorelli, Robert J. Van Geuns, Bernard Chevalier, Marco Perin, Rodolfo Staico, Roberto Botelho, Ashok Seth, Patrick W. Serruys

Journal of the American College of Cardiology

Article2014

1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds

Takashi Muramatsu, Yoshinobu Onuma, Robert‐Jan van Geuns, Bernard Chevalier, Tejas Patel, Ashok Seth, Roberto Diletti, Héctor M. García‐García, Cécile Dorange, Susan Veldhof, Wai-Fung Cheong, Yukio Ozaki, Robert Whitbourn, Antonio L. Bartorelli, Gregg W. Stone, Alexandre Abizaid, Patrick W. Serruys

КАРДИОЛОГИЯ УЗБЕКИСТАНА

Abstract

Discussion(0)

Related publications

TCT-36 One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSORB EXTEND Trials.

TCT-60 1-year Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis from the ABSORB Randomized Trials

TCT-62 Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

TCT-624 Impact of Post Dilation on the Acute and One-Year Clinical Outcomes of a Large Cohort of Patients Treated Solely With the Absorb Bioresorbable Vascular Scaffold

1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds